Ads
related to: bmrn stock price today
Search results
BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Finance· 3 days agoThe headline numbers for BioMarin (BMRN) give insight into how the company performed in the quarter...
Is a Surprise Coming for BioMarin (BMRN) This Earnings Season?
Zacks· 5 days agoThis suggests that analysts have very recently bumped up their estimates for BMRN, giving the stock a Zacks Earnings ESP of +21.30% heading into earnings ...
Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks· 6 days agoBesides Wall Street's top -and-bottom-line estimates for BioMarin (BMRN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Rose 8.64% From Its 52-Week Low, But YTD Numbers Fell...
Marketing Sentinel· 3 days ago(NASDAQ:BMRN)’s traded shares were 4.98 million, with the beta value of the company hitting 0.31. At the last check today, the stock’ ...
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
Zacks via Yahoo Finance· 3 days agoBioMarin (BMRN) delivered earnings and revenue surprises of 18.33% and 0.14%, respectively, for the...
BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales
Zacks via Yahoo Finance· 3 days agoBioMarin's (BMRN) earnings beat estimates in the first quarter of 2024, while revenues slightly miss...
BioMarin Pharmaceutical, Inc. (BMRN) Q1 2024 Earnings Call Transcript
Seeking Alpha· 3 days agoBioMarin Pharmaceutical, Inc. (NASDAQ:NASDAQ:BMRN) Q1 2024 Earnings Conference Call April 24, 2024 4:30 PM ETCompany ParticipantsTraci McCarty - Head of...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 days agoBioMarin’s stock has declined 7% in the past year. BioMarin topped earnings estimates in three of...
BioMarin Reports Record Financial Results for the First Quarter 2024
Fontana Herald News· 3 days agoBioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the quarter ended March 31, 2024. By advancing and focusing on these promising ...
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's...
Benzinga· 2 days agoBioMarin Pharmaceutical Inc . BMRN dipped 9% to $83.05 after the company reported first-quarter financial results. Reliance, Inc . RS fell 8.8% to...AZZ Inc . AZZ dipped 8.6% ...
